L1, termed IB101, which was found to form a defined binding pocket that precisely positions the active moiety in a reactive conformation.

The host immune "recognition" of cancer forms the basis of modern tumor immmunotherapy, a highly targeted treatment option with the demonstrated ability to "cure" previously lethal blood cancers.

Misbehaving proteins are behind many diseases. One way drugmakers incapacitate these bad actors is to deploy molecules that bind to them. But finding solid footholds on the proteins to block their ...

A new method for learning the structures of small molecules, such as hormones, is 'like science fiction.' In a new study that one scientist called jaw-dropping, a joint UCLA/Caltech team has shown ...

Terremoto Biosciences has launched with $75 million in series A financing to discover small-molecule drugs using its lysine-targeted covalency technology. Terremoto says most drugs that bind to ...

Chronic kidney disease (CKD) and acute kidney injury (AKI) represent a massive global health burden, affecting millions worldwide and driving a rising ...